Abstract
Background
Metastatic lesions to the pancreas are uncommon. The most frequent metastases are from renal cell carcinoma (RCC). We analyzed the clinical features and survival of patients with pancreatic metastasis from renal cell carcinoma.
Methods
We retrospectively reviewed the clinical records of patients with pancreatic metastases from RCC, observed in our department from January 2004 to March 2010. Follow-up continued to September 2013.
Results
In the study period 13 patients with a diagnosis of metastasis from RCC were observed in our clinic, and among them 9 pancreatic resections were performed (2 pancreaticoduodenectomy, 1 duodenum-preserving pancreatic head resection, 1 central pancreatectomy, and 5 distal pancreatectomy). Four patients did not undergo a pancreatic resection: two refused surgery, one had an endoscopic biliary stent for jaundice placed and then underwent a surgical biliary bypass, and the fourth patient was too advanced and had only an endoscopic biliary stent. The mean follow-up was 56 months (range 5–115, median 53), with one nonresected patient lost in follow-up after 38 months. Among the other 12 patients, 4 died: two for progression of disease 5 and 20 months respectively after our observation. The mean (±SEM) disease-free survival of seven resected patients with curative intent was 40 ± 11 months (median 34).
Conclusions
Pancreatic metastases from RCC are often asymptomatic. They generally present slow growth and an indolent behavior. Surgery is the treatment of choice in those patients with only pancreatic involvement, achieving long-term survival and disease-free survival.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zerbi A, Ortolano E, Balzano G et al (2008) Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol 15:1161–1168
Schauer M, Vogelsang H, Siewert JR (2008) Pancreatic resection for metastatic renal cell carcinoma: a single centre experience and review of the literature. Anticancer Res 28:361–365
Ballarin R, Spaggiari M, Cautero N, De Ruvo N, Montalti R, Longo C, Pecchi A, Giacobazzi P, De Marco G, D’Amico G, Gerunda GE, Di Benedetto F (2011) Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol 17(43):4747–4756. doi:10.3748/wjg.v17.i43.4747
Thompson LD, Heffess CS (2000) Renal cell carcinoma to the pancreas in surgical pathology material. A clinicopathologic study of 21 cases with a review of the literature. Cancer 89:1076–1088
Tanis PJ, van der Gaag NA, Busch OR et al (2009) Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Br J Surg 96:579–592
Volk A, Kersting S, Konopke R et al (2009) Surgical therapy of intrapancreatic metastasis from renal cell carcinoma. Pancreatology 9:392–397
Kassabian A, Stein J, Jabbour N et al (2000) Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature. Urology 56:211–215
Reddy S, Edil BH, Cameron JL et al (2008) Pancreatic resection of isolated metastases from nonpancreatic primary cancers. Ann Surg Oncol 15:3199–3206
Sohn TA, Yeo CJ, Cameron JL et al (2001) Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg 5:346–351
Lee C, You D, Park J et al (2011) Validation of the 2009 TNM classification for renal cell carcinoma: comparison with the 2002 TNM classification by concordance index. Korean J Urol 52:524–530
Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13
Maldazys JD, deKernion JB (1986) Prognostic factors in metastatic renal carcinoma. J Urol 136:376–379
Ritchie AWS, deKernion JB (1987) The natural history and clinical features of renal carcinoma. Semin Nephrol 7:131–139
Bassi C, Butturini G, Falconi M et al (2003) High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg 90:555–559
Klein KA, Stephens DH, Welch TJ (1998) CT characteristics of metastatic disease of the pancreas. Radiographics 18:369–378
Sperti C, Pasquali C, Liessi G et al (2003) Pancreatic resection for metastatic tumors to the pancreas. J Surg Oncol 83:161–166
Ghavamian R, Klein KA, Stephens DH et al (2000) Renal cell carcinoma metastatic to the pancreas: clinical and radiological features. Mayo Clin Proc 75:581–585
Edgren M, Westlin JE, Kälkner KM et al (1999) [111In-DPTA-D-Phe1]-octreotide scintigraphy in the management of patients with advanced renal cell carcinoma. Cancer Biother Radiopharm 14:59–64
Mueller-Lisse UG, Mueller-Lisse UL (2010) Imaging of advanced renal cell carcinoma. World J Urol 28:253–261. doi:10.1007/s00345-010-0557-z
Niess H, Conrad C, Kleespies A et al (2013) Surgery for metastasis to the pancreas: is it safe and effective? J Surg Oncol 107:859–864
Masetti M, Zanini N, Martuzzi F et al (2010) Analysis of prognostic factors in metastatic tumors of the pancreas. A single centre experience and review of the literature. Pancreas 39:135–143
Grassi P, Verzoni E, Mariani L et al (2013) Prognostic role of pancreatic metastases from renal cell carcinoma: results from an Italian center. Clin Genitourin Cancer 11:484–488
Conflict of interest
The authors have no potential conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moletta, L., Milanetto, A.C., Vincenzi, V. et al. Pancreatic Secondary Lesions from Renal Cell Carcinoma. World J Surg 38, 3002–3006 (2014). https://doi.org/10.1007/s00268-014-2672-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-014-2672-2